@gift-bravetg
Immunotherapy has seen breakthroughs such as next-generation CAR-T cell treatments and combination therapies with immune checkpoint inhibitors. These advances have significantly improved clinical outcomes, especially for cancers once considered untreatable. Patients with blood cancers and some solid tumors now experience higher remission rates and prolonged survival, marking a major step forward in personalized medicine.